tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Ambev S.A. Reports June 2025 Securities Transactions

Story Highlights
Ambev S.A. Reports June 2025 Securities Transactions

Elevate Your Investing Strategy:

Ambev SA ( (ABEV) ) has issued an announcement.

In June 2025, Ambev S.A. reported transactions involving securities and derivatives as per CVM Instruction # 358/2002. The company’s management sold shares through Itaú Corretora, totaling a volume of R$1,816,950.00, indicating active management of its securities portfolio. These transactions reflect Ambev’s ongoing efforts to manage its financial assets effectively, which could impact its financial stability and shareholder value.

The most recent analyst rating on (ABEV) stock is a Sell with a $2.10 price target. To see the full list of analyst forecasts on Ambev SA stock, see the ABEV Stock Forecast page.

Spark’s Take on ABEV Stock

According to Spark, TipRanks’ AI Analyst, ABEV is a Outperform.

Ambev SA’s overall stock score reflects strong financial performance and a positive earnings outlook, balanced by moderate technical and valuation indicators. The company’s robust growth in key areas and commitment to shareholder returns are significant strengths, although regional market challenges and upcoming cost pressures are notable considerations.

To see Spark’s full report on ABEV stock, click here.

More about Ambev SA

Ambev S.A. is a leading beverage company based in São Paulo, Brazil, primarily engaged in the production and distribution of beer, soft drinks, and other beverages. The company operates in the beverage industry and has a significant market presence in Latin America.

Average Trading Volume: 32,457,673

Technical Sentiment Signal: Buy

Current Market Cap: $38.47B

Find detailed analytics on ABEV stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1